RCUS
Arcus Biosciences, Inc.
+1.12 (+4.54%)25.77USD615K成交股數3.3B市值–本益比(近四季)57.6股價營收比+312.5%營收年增(近四季)2026-10-27下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 8 · 3.0M · 2 |
| 其中 10b5-1 計畫賣出 | 8 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 3.3M |
| 近 180 天 淨額 | −3.3M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-21 | 08-24 | Azoy Alexander | Chief Accounting Officer | M 選擇權執行 | 2.8K | 15.44 | 44K | 42.4K | SEC |
| 2026-08-21 | 08-24 | Azoy Alexander | Chief Accounting Officer | S 公開市場賣出(10b5-1) | 2.8K | 30.00 | 85K | 39.6K | SEC |
| 2026-07-10 | 07-13 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 19.8K | 28.61 | 566K | 823K | SEC |
| 2026-07-10 | 07-13 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 268 | 29.40 | 8K | 822K | SEC |
| 2026-07-09 | 07-13 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 48.5K | 30.05 | 1.5M | 842K | SEC |
| 2026-06-24 | 06-24 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 6.4K | 29.66 | 191K | 891K | SEC |
| 2026-06-23 | 06-24 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 1.7K | 28.06 | 48K | 897K | SEC |
| 2026-06-23 | 06-24 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 14.1K | 27.69 | 390K | 899K | SEC |
| 2026-06-22 | 06-24 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 9.2K | 27.03 | 250K | 913K | SEC |
| 2026-06-11 | 06-12 | Lacey David L. | Director | A 獲配股票 | 5.7K | – | – | 76.7K | SEC |
| 2026-06-11 | 06-12 | Machado Patrick | Director | A 獲配股票 | 5.7K | – | – | 44.3K | SEC |
| 2026-06-11 | 06-12 | KANEKO YASUNORI | Director | A 獲配股票 | 5.7K | – | – | 25.7K | SEC |
| 2026-06-11 | 06-12 | FALBERG KATHRYN E | Director | A 獲配股票 | 5.7K | – | – | 44.3K | SEC |
| 2026-06-11 | 06-12 | Lambert Nicole | Director | A 獲配股票 | 5.7K | – | – | 43.0K | SEC |
| 2026-06-11 | 06-12 | PERLMAN ANDREW J | Director | A 獲配股票 | 5.7K | – | – | 48.3K | SEC |
| 2026-06-11 | 06-12 | Tang Carolyn C. | General Counsel | M 選擇權執行 | 34.1K | 2.57 | 88K | 185K | SEC |
| 2026-06-11 | 06-12 | Ribas Antoni | Director | A 獲配股票 | 5.7K | – | – | 44.3K | SEC |
| 2026-06-01 | 06-01 | Azoy Alexander | Chief Accounting Officer | S 公開市場賣出(10b5-1) | 2.6K | 25.77 | 66K | 39.6K | SEC |
| 2026-05-11 | 05-12 | Goeltz II Robert C. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 7.8K | 25.63 | 199K | 84.2K | SEC |
| 2026-01-23 | 01-26 | Jarrett Jennifer | Chief Operating Officer | A 獲配股票 | 31.0K | – | – | 224K | SEC |
| 2026-01-23 | 01-26 | Markus Richard | Chief Medical Officer | A 獲配股票 | 24.0K | – | – | 89.6K | SEC |
| 2026-01-23 | 01-26 | Tang Carolyn C. | General Counsel | A 獲配股票 | 24.0K | – | – | 149K | SEC |
| 2026-01-23 | 01-26 | Azoy Alexander | Chief Accounting Officer | A 獲配股票 | 21.1K | – | – | 39.6K | SEC |
| 2026-01-23 | 01-26 | Goeltz II Robert C. | Chief Financial Officer | A 獲配股票 | 24.0K | – | – | 91.9K | SEC |
| 2026-01-23 | 01-26 | Jaen Juan C. | President | A 獲配股票 | 31.0K | – | – | 377K | SEC |
| 2026-01-23 | 01-26 | ROSEN TERRY J | Chief Executive Officer | A 獲配股票 | 79.0K | – | – | 2.2M | SEC |
| 2026-01-08 | 01-09 | ROSEN TERRY J | Chief Executive Officer | G 贈與 | 35.0K | – | – | 2.2M | SEC |
| 2026-01-05 | 01-07 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 100 | 23.20 | 2K | 922K | SEC |
| 2026-01-05 | 01-07 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 2.1K | 22.34 | 46K | 922K | SEC |
| 2026-01-05 | 01-07 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 29.7K | 21.34 | 633K | 924K | SEC |
| 2025-12-31 | 01-02 | Goeltz II Robert C. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 6.6K | 23.38 | 153K | 67.9K | SEC |
| 2025-12-30 | 01-02 | ROSEN TERRY J | Chief Executive Officer | G 贈與 | 2.4K | – | – | 2.2M | SEC |
| 2025-12-18 | 12-18 | Azoy Alexander | Chief Accounting Officer | S 公開市場賣出(10b5-1) | 4.3K | 22.25 | 97K | 18.5K | SEC |
| 2025-12-17 | 12-18 | Markus Richard | Chief Medical Officer | S 公開市場賣出(10b5-1) | 4.5K | 22.16 | 100K | 65.6K | SEC |
| 2025-12-17 | 12-18 | Tang Carolyn C. | General Counsel | S 公開市場賣出(10b5-1) | 6.8K | 22.16 | 151K | 125K | SEC |
| 2025-12-17 | 12-18 | Azoy Alexander | Chief Accounting Officer | S 公開市場賣出(10b5-1) | 2.1K | 22.16 | 47K | 22.9K | SEC |
| 2025-12-17 | 12-18 | Jarrett Jennifer | Chief Operating Officer | S 公開市場賣出(10b5-1) | 10.0K | 22.16 | 221K | 193K | SEC |
| 2025-12-17 | 12-18 | ROSEN TERRY J | Chief Executive Officer | S 公開市場賣出(10b5-1) | 25.7K | 22.16 | 570K | 2.2M | SEC |
| 2025-12-17 | 12-18 | Goeltz II Robert C. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 6.0K | 22.16 | 132K | 74.5K | SEC |
| 2025-12-17 | 12-18 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 10.0K | 22.16 | 221K | 346K | SEC |
| 2025-12-16 | 05-12 | Ribas Antoni | Director | G 贈與 | 5.0K | – | – | 38.6K | SEC |
| 2025-12-16 | 12-18 | ROSEN TERRY J | Chief Executive Officer | S 公開市場賣出(10b5-1) | 28.9K | 21.88 | 633K | 2.2M | SEC |
| 2025-12-16 | 12-18 | Markus Richard | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.1K | 21.88 | 111K | 70.1K | SEC |
| 2025-12-16 | 12-18 | Tang Carolyn C. | General Counsel | S 公開市場賣出(10b5-1) | 7.7K | 21.88 | 168K | 132K | SEC |
| 2025-12-16 | 12-18 | Azoy Alexander | Chief Accounting Officer | S 公開市場賣出(10b5-1) | 2.4K | 21.88 | 52K | 25.0K | SEC |
| 2025-12-16 | 12-18 | Jarrett Jennifer | Chief Operating Officer | S 公開市場賣出(10b5-1) | 11.2K | 21.88 | 246K | 203K | SEC |
| 2025-12-16 | 12-18 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 11.2K | 21.88 | 246K | 356K | SEC |
| 2025-12-16 | 12-18 | Goeltz II Robert C. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 6.7K | 21.88 | 147K | 80.4K | SEC |
| 2025-12-04 | 12-05 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 83.0K | 24.71 | 2.1M | 954K | SEC |
| 2025-11-26 | 12-01 | Azoy Alexander | Chief Accounting Officer | M 選擇權執行 | 1.9K | 13.33 | 25K | 29.3K | SEC |
| 2025-11-26 | 12-01 | Azoy Alexander | Chief Accounting Officer | S 公開市場賣出(10b5-1) | 1.9K | 26.00 | 49K | 27.4K | SEC |
| 2025-11-26 | 11-26 | Goeltz II Robert C. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 5.0K | 25.00 | 125K | 87.1K | SEC |
| 2025-11-18 | 11-19 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 5.0K | 19.75 | 100K | 1.0M | SEC |
| 2025-11-17 | 11-19 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 7.8K | 20.71 | 162K | 1.0M | SEC |
| 2025-11-17 | 11-19 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 37.1K | 20.23 | 751K | 1.0M | SEC |
| 2025-11-07 | 11-12 | Jarrett Jennifer | Chief Operating Officer | M 選擇權執行 | 50.3K | 1.23 | 62K | 265K | SEC |
| 2025-11-07 | 11-12 | Jarrett Jennifer | Chief Operating Officer | S 公開市場賣出(10b5-1) | 50.3K | 18.97 | 954K | 214K | SEC |
| 2025-10-30 | 11-03 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 4.3K | 20.32 | 88K | 1.1M | SEC |
| 2025-10-29 | 10-30 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 800 | 22.04 | 18K | 1.1M | SEC |
| 2025-10-29 | 10-30 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 29.4K | 21.53 | 632K | 1.1M | SEC |
| 2025-10-29 | 10-30 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 47.7K | 20.49 | 977K | 1.1M | SEC |
| 2025-10-28 | 10-30 | Jaen Juan C. | President | S 公開市場賣出(10b5-1) | 19.0K | 20.19 | 384K | 1.2M | SEC |
| 2025-10-28 | 10-29 | Goeltz II Robert C. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 5.0K | 20.00 | 100K | 92.1K | SEC |
| 2025-10-08 | 10-08 | Jarrett Jennifer | Chief Operating Officer | M 選擇權執行 | 37.8K | 1.23 | 46K | 252K | SEC |
| 2025-10-08 | 10-08 | Jarrett Jennifer | Chief Operating Officer | S 公開市場賣出(10b5-1) | 37.8K | 15.05 | 569K | 214K | SEC |
| 2025-10-06 | 10-08 | Jarrett Jennifer | Chief Operating Officer | S 公開市場賣出(10b5-1) | 12.5K | 14.54 | 182K | 214K | SEC |
| 2025-10-06 | 10-08 | Jarrett Jennifer | Chief Operating Officer | M 選擇權執行 | 12.5K | 1.23 | 15K | 227K | SEC |
| 2025-09-29 | 09-30 | Azoy Alexander | Chief Accounting Officer | S 公開市場賣出(10b5-1) | 2.8K | 13.00 | 37K | 27.4K | SEC |
| 2025-09-05 | 09-05 | Azoy Alexander | Chief Accounting Officer | S 公開市場賣出(10b5-1) | 1.6K | 11.88 | 19K | 30.2K | SEC |
| 2025-06-10 | 06-12 | Ribas Antoni | Director | A 獲配股票 | 13.3K | – | – | 43.6K | SEC |
| 2025-06-10 | 06-12 | Lacey David L. | Director | A 獲配股票 | 13.3K | – | – | 71.0K | SEC |
| 2025-06-10 | 06-12 | PERLMAN ANDREW J | Director | A 獲配股票 | 13.3K | – | – | 42.6K | SEC |
| 2025-06-10 | 06-12 | KANEKO YASUNORI | Director | A 獲配股票 | 13.3K | – | – | 33.3K | SEC |
| 2025-06-10 | 06-12 | FALBERG KATHRYN E | Director | A 獲配股票 | 13.3K | – | – | 68.6K | SEC |
| 2025-06-10 | 06-12 | Machado Patrick | Director | A 獲配股票 | 13.3K | – | – | 38.6K | SEC |
| 2025-06-10 | 06-12 | Lambert Nicole | Director | A 獲配股票 | 13.3K | – | – | 37.3K | SEC |
| 2025-02-27 | 02-27 | ROSEN TERRY J | Chief Executive Officer | P 公開市場買進 | 19.8K | 10.18 | 202K | 2.6M | SEC |
| 2025-02-27 | 02-27 | KANEKO YASUNORI | Director | P 公開市場買進 | 20.0K | 10.06 | 201K | 28.4K | SEC |
| 2025-02-18 | 02-20 | GILEAD SCIENCES, INC. | TenPercentOwner | P 公開市場買進 | 1.4M | 11.00 | 15.0M | 31.4M | SEC |
| 2025-02-10 | 02-11 | Markus Richard | Chief Medical Officer | A 獲配股票 | 75.2K | – | – | 75.2K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 31.4M | 969M | 新進 | 新進 |
| BlackRock, Inc. | 16.4M | 506M | 新進 | 新進 |
| STATE STREET CORP | 6.0M | 186M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 5.9M | 182M | 新進 | 新進 |
| MONTANOVA CAPITAL, LLC | 4.8M | 147M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.5M | 138M | 新進 | 新進 |
| FMR LLC | 4.0M | 125M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9M | 120M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 3.1M | 96.7M | 新進 | 新進 |
| Woodline Partners LP | 3.0M | 92.7M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4M | 75.5M | 新進 | 新進 |
| Siren, L.L.C. | 2.4M | 74.6M | 新進 | 新進 |
| Fisher Asset Management, LLC | 2.1M | 66.0M | 新進 | 新進 |
| MARSHALL WACE, LLP | 1.9M | 60.0M | 新進 | 新進 |
| SAMLYN CAPITAL, LLC | 1.5M | 47.7M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 1.4M | 44.2M | 新進 | 新進 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.4M | 43.8M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 1.4M | 42.8M | 新進 | 新進 |
| Soleus Capital Management, L.P. | 1.2M | 36.0M | 新進 | 新進 |
| Sofinnova Investments, Inc. | 946K | 29.2M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 942K | 29.0M | 新進 | 新進 |
| NORTHERN TRUST CORP | 933K | 28.7M | 新進 | 新進 |
| Parkman Healthcare Partners LLC | 919K | 28.3M | 新進 | 新進 |
| Invesco Ltd. | 845K | 26.1M | 新進 | 新進 |
| BAKER BROS. ADVISORS LP | 845K | 26.0M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 230 +19 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 230 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 123M · 96.3% |
| 合計季末市值 | 3.7B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 13.1M |
|---|---|
| 與上期比 | -5.6% |
| 佔流通股數 | 10.27% |
| 日均成交量 | 1.2M |
| 回補天數 | 11.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 13.1M | -5.6% | 10.27% | 1.2M | 11.0 |
| 2026-08-14 | 13.8M | +5.6% | 10.88% | 1.1M | 12.3 |
| 2026-07-31 | 13.1M | +4.5% | 10.30% | 1.1M | 11.6 |
| 2026-07-15 | 12.6M | -0.7% | 9.86% | 972K | 12.9 |
| 2026-06-30 | 12.6M | -4.7% | 9.93% | 2.1M | 5.9 |
| 2026-06-15 | 13.3M | +13.3% | 10.42% | 1.2M | 10.9 |
| 2026-05-29 | 11.7M | +7.5% | 9.19% | 929K | 12.6 |
| 2026-05-15 | 10.9M | +0.1% | 8.55% | 971K | 11.2 |
| 2026-04-30 | 10.9M | -1.8% | 8.54% | 1.7M | 6.5 |
| 2026-04-15 | 11.1M | +12.1% | 8.70% | 910K | 12.2 |
| 2026-03-31 | 9.9M | +14.7% | 7.76% | 1.2M | 8.1 |
| 2026-03-13 | 8.6M | -7.1% | 6.76% | 1.4M | 6.1 |
| 2026-02-27 | 9.3M | +2.9% | 7.28% | 1.2M | 7.6 |
| 2026-02-13 | 9.0M | +9.9% | 7.07% | 921K | 9.8 |
| 2026-01-30 | 8.2M | -7.9% | 6.44% | 934K | 8.8 |
| 2026-01-15 | 8.9M | -7.2% | 6.99% | 1.8M | 5.0 |
| 2025-12-31 | 9.6M | +22.5% | 7.53% | 1.7M | 5.6 |
| 2025-12-15 | 7.8M | -13.8% | 6.15% | 2.6M | 3.1 |
| 2025-11-28 | 9.1M | -8.1% | 7.14% | 1.9M | 4.9 |
| 2025-11-14 | 9.9M | +18.5% | 7.77% | 1.9M | 5.3 |
| 2025-10-31 | 8.3M | -3.6% | 6.55% | 1.7M | 4.8 |
| 2025-10-15 | 8.7M | -12.5% | 6.80% | 1.3M | 6.5 |
| 2025-09-30 | 9.9M | -9.2% | 7.77% | 929K | 10.7 |
| 2025-09-15 | 10.9M | +10.8% | 8.56% | 867K | 12.6 |
| 2025-08-29 | 9.8M | +8.1% | 7.72% | 617K | 16.0 |
| 2025-08-15 | 9.1M | +1.4% | 7.14% | 870K | 10.5 |